Documents required for Ghana FDA product registration

Most delays in Ghana FDA registration trace back to one thing: a dossier that is missing documents or carries inconsistencies between them. The Ghana FDA accepts submissions in the Common Technical Document (CTD) format, in line with ICH guidelines (M4), and it will not advance an application until the file is validated as complete.

This is the checklist we use to make a submission audit-ready. Exact requirements vary by product category — human medicines, veterinary products, food supplements and cosmetics each differ — so treat this as the core backbone, not a substitute for the current FDA guidance for your specific product.

The CTD: five modules

The CTD organises your dossier into five modules. Module 1 is region-specific to Ghana; Modules 2–5 follow the international structure.

• Module 1 — Administrative & product information: completed application form, proposed labelling and artwork, patient information leaflet, and Ghana-specific administrative documents.
• Module 2 — Summaries: overviews and summaries of quality, safety (non-clinical) and efficacy (clinical) data.
• Module 3 — Quality (CMC): chemistry, manufacturing and controls — specifications, manufacturing process, and stability data.
• Module 4 — Non-clinical: pharmacology and toxicology study reports, where applicable to the product.
• Module 5 — Clinical: clinical study reports supporting safety and efficacy, where applicable.

Key supporting documents

Alongside the CTD modules, these documents are routinely required and are common points of failure:

Certificate of Pharmaceutical Product (CPP)

For any product manufactured outside Ghana, a valid CPP (in the WHO format) from the competent authority in the country of manufacture must be provided before market authorisation is issued. A missing or expired CPP is one of the most common avoidable stoppages.

GMP certificate

Evidence of Good Manufacturing Practice compliance for the manufacturing site. The FDA may also conduct or require a site inspection, so the certificate must reflect the actual facility producing the product.

Labelling and artwork

Product labelling in English, meeting Ghana FDA content and format requirements. Get this reviewed before printing — artwork errors are a frequent source of queries and reprints.

Quality, safety and efficacy data

Specifications, certificates of analysis, stability data appropriate to Ghana's climatic zone, and the safety/efficacy evidence appropriate to the product class.

A practical pre-submission checklist

1. Completed FDA application form for the correct product category
2. Full CTD dossier (Modules 1–5 as applicable)
3. Valid CPP for foreign-manufactured products
4. Current GMP certificate for the actual manufacturing site
5. English labelling, packaging artwork and patient information leaflet
6. Certificates of analysis and stability data
7. Consistent product details across every document

Our dossier preparation and evaluation service runs exactly this audit — identifying and fixing gaps before the file reaches the FDA, which is where most avoidable deficiencies are eliminated.

Samuel E.K. AgyeiB.Pharm, MPSGHManaging Director & Licensed Pharmacist, SCS Pharma Consult — Ghana FDA regulatory affairs, GMP compliance and pharmaceutical market entry.